No abstract available
Keywords:
Byetta; Mounjaro; Trulicity; Victoza; Wegovy; Zepound; adverse effects; cardiovascular disease; dosage; dulaglutide; efficacy; exenatide; liraglutide; safety; semaglutide; tirzepatide; weight loss.
MeSH terms
-
Diabetes Mellitus, Type 2* / drug therapy
-
Glucagon-Like Peptides* / administration & dosage
-
Glucagon-Like Peptides* / adverse effects
-
Glucagon-Like Peptides* / therapeutic use
-
Humans
-
Hypoglycemic Agents* / administration & dosage
-
Hypoglycemic Agents* / adverse effects
-
Hypoglycemic Agents* / therapeutic use
Substances
-
semaglutide
-
Glucagon-Like Peptides
-
Hypoglycemic Agents